Open access · CC-BY
via OpenAlex
Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes
Ana Raimundo, Sofia Ferreira, Francisco Abraham Tomás-Barberán, Cláudia Nunes dos Santos, Regina Menezes
Nutrients · 2021 · ▲ 40 citations
Abstract
Diabetes remains one of the leading causes of deaths and co-morbidities in the world, with tremendous human, social and economic costs. Therefore, despite therapeutics and technological advancements, improved strategies to tackle diabetes management are still needed. One of the suggested strategies is the consumption of (poly)phenols. Positive outcomes of dietary (poly)phenols have been pointed out towards different features in diabetes. This is the case of ellagitannins, which are present in numerous foodstuffs such as pomegranate, berries, and nuts. Ellagitannins have been reported to have a multitude of effects on metabolic diseases. However, these compounds have high molecular weight and do not reach circulation at effective concentrations, being metabolized in smaller compounds. After being metabolized into ellagic acid in the small intestine, the colonic microbiota hydrolyzes and metabolizes ellagic acid into dibenzopyran-6-one derivatives, known as urolithins. These low molecular weight compounds reach circulation in considerable concentrations ranging until micromolar levels, capable of reaching target tissues. Different urolithins are formed throughout the metabolization process, but urolithin A, isourolithin A, and urolithin B, and their phase-II metabolites are the most frequent ones. In recent years, urolithins have been the focus of attention in regard to their effects on a multiplicity of chronic diseases, including cancer and diabetes. In this review, we will discuss the latest advances about the protective effects of urolithins on diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/nu13124285
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Raimundo, A., Ferreira, S., Tomás-Barberán, F.A., Santos, C.N.D., & Menezes, R. (2021). Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes. <em>Nutrients</em>. https://doi.org/10.3390/nu13124285
Vancouver
Raimundo A, Ferreira S, Tomás-Barberán FA, Santos CND, Menezes R. Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes. Nutrients. 2021. doi:10.3390/nu13124285.
BibTeX
@article{ana2021Urolit,
title = {Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes},
author = {Ana Raimundo and Sofia Ferreira and Francisco Abraham Tomás-Barberán and Cláudia Nunes dos Santos and Regina Menezes},
journal = {Nutrients},
year = {2021},
doi = {10.3390/nu13124285},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oxidative Medicine and Cellular Longevity 2020
Open access · CC-BY
Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress
Neural Regeneration Research 2019
Open access · CC-BY
Induced pluripotent stem cells from Huntington’s disease patients: a promising approach to define and correct disease-related alterations
International Journal of Molecular Sciences 2021
Open access · CC-BY
What Are Reactive Oxygen Species, Free Radicals, and Oxidative Stress in Skin Diseases?
mSphere 2025
Open access · CC-BY
Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy
Experimental Gerontology 2017
Open access · CC-BY
Pleiotropic responses to methionine restriction
MDPI eBooks 2019
Open access · CC-BY